Clinical Trial Update: Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 1/2 study evaluating Calcitriol with Ketoconazole and hydrocortisone for prostate cancer; the study was terminated and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• CORTEF (HYDROCORTISONE)
• NIZORAL (Ketoconazole)
• Rocaltrol (calcitriol)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Prostate Adenocarcinoma, Recurrent Prostate Carcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-05-15